ClinicalTrials.gg
Status unknownNCT01155271OBEX1Updated Oct 2, 2018

OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training

An interventional study of Rehabilitation in Obesity and Sleep Apnea, sponsored by AGIR à Dom. Status unknown at 2 sites in 2 countries. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-10-02.

Sponsored by AGIR à Dom · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 575 studies in Obesity with a site in Canada — 102 open to participants now, 151 under way, 47 of them phase 3. Obesity · Canada.

Enrollment
261st of 480
60 · median 74
Started
2010
with 24 others
No phase
280 of 575
34 open now
Registered
85th of 575
by date

Among the 575 studies in Obesity with a site in Canada, this one is the 261st largest by enrollment of the 480 interventional ones that give a count, is one of 25 that started in 2010, is one of 280 with no phase, and was the 85th registered.

Obesity

11,560 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

102 of the 575 studies in Obesity with a site in Canada are open now. Recruiting first, the newest first:

97 more — sign in →

All 102 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 575 studies in Obesity with a site in Canada, or all of them as a file.
02

Study summary

The study was designed to test the following hypotheses:

In obese patients with OSAS, the benefit of the combination of exercise training + continuous positive airway pressure (CPAP) will be higher than CPAP alone in term of functional capacity, metabolic, inflammatory, cardiovascular and sleep parameters and quality of life.

In obese patients with OSAS, the benefit of training using ventilatory assistance (NIV) during cycloergometer [cycloergometer with NIV] or respiratory muscles training (spirotiger) in addition to cycloergometer [cycloergometer + spirotiger] will be higher than cycloergometer training alone [cycloergometer] in term of functional and exercise capacities.

Dyspnea during walking test and respiratory muscle strength at baseline could influence the response to combined exercise training such as [cycloergometer + NIV] or [cycloergometer + spirotiger]

Read the detailed description

Background: Obesity and sleep apnea syndrome lead to metabolic troubles and increasing cardiovascular risk. Furthermore, both diseases are associated with reduced exercise tolerance. We hypothesized that exercise training could be complementary to nocturnal ventilatory treatment in restoring metabolic disturbances, exercise tolerance and sleep parameters in obese patients with SAS.

Objective: To evaluate the effect of training on exercise tolerance (walking distance and dyspnea during walk)(main objective), systemic inflammation, vascular endothelial function, insulin resistance, quality of sleep and quality of life in obese patients treated by CPAP for OSAS (secondary objectives)

Methods: We proposed to conduct a controlled, randomized clinical trial comparing the efficacy of 3 different modalities of training in obese patients with SAS. After a 6-week control pre-inclusion period, patients are included in either [cycloergometer] vs. [cycloergometer with ventilatory assistance] vs. [cycloergometer + respiratory muscle exercises]. Before and after the control period, and both immediately and 9 month after training, patients perform walking test, maximal incremental test on cycloergometer, blood sampling and cardiovascular function, body composition, muscle function, quality of sleep and quality of life assessments as well as spontaneous physical activity measurement. During the 5 years following inclusion in the training program, the number of cardiovascular event is recorded every year.

An interim analysis will be carried out when 30 will have completed the third evaluation session (after the training program). The Peto's method will be used to correct the p-values.

03

Conditions studied

  • Obesity
  • Sleep Apnea
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • OSAS (AHI > 30 before CPAP treatment)
  • > 4h/d CPAP treatment adherence
  • Obese patients with 35 \< \< 45 kg/m2
  • Patients who give written consent
  • Patients who subscribed social insurance

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study
  • to exercise
  • Pregnant or breast-feed woman
  • Patients under guardianship
  • Imprisoned patients
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    ERGO

    General endurance training on cycloergometer

    Other: Rehabilitation

  • Active comparator
    ERGONIV/ ERGOSPIRO

    General endurance training on cycloergometer using ventilatory assistance (ERGONIV) or additional respiratory muscle training (ERGOSPIRO)

    Other: Rehabilitation

Interventions

  • OtherRehabilitation

    12 weeks : 3 sessions per week (2 supervised sessions and 1 session at home) 1 technical visit and 1 nursing visit every two months at home for the CPAP

06

What researchers measure

Primary outcomes

  1. Change in exercise tolerance during walking test

    * walking distance * dyspnea score

    Time frame: After control period (6th wk) vs. after training period (18th wk)

Secondary outcomes

  1. Changes in Aerobic capacity

    Maximal oxygen consumption

    Time frame: After control period (6th wk) vs. after training period (18th and 52th wks)

  2. Changes in cardiovascular and metabolic function

    Pulse wave velocity, peripheral arterial tone, BP, inflammatory and metabolic plasmatic markers

    Time frame: After control period (6th wk) vs. after training period (18th and 52th wks)

  3. Changes in sleep parameters and Quality Of life

    Nocturnal oxygen saturation, CPAP data, Epworth questionnaire, Short Form (36) Health Survey questionnaire

    Time frame: After control period (6th wk) vs. after training period (18th and 52th wks)

  4. Number of cardiovascular events per year

    Questionnaire sent to the patient by mail

    Time frame: Every year from the 1st to the 5th year

  5. Changes in body composition

    Fat mass and fat-mass index Fat-free mass and fat-free mass index assessed by impedancemetry measurements

    Time frame: After control period (6th wk) vs. after training period (18th and 52th wks)

  6. Change in physical activity and sleep duration

    Number of hour per day of physical activity at 1, 2, 3 or 4 Metabolic Equivalents (METS); Number of steps per day; Sleep to lying position duration ratio

    Time frame: After control period (6th wk) vs. after training period (18th and 52th wks)

  7. Change in exercise tolerance during walking test

    * isotime dyspnea * isotime oxygen saturation

    Time frame: After control period (6th wk) vs. after trainng (52th wk)

  8. Change in physiological variables during the control period

    * functional and exercise parameters * cardiovascular parameters * metabolic parameters * sleep and quality of life parameters (Short Form (36) Health Survey) * physical activity

    Time frame: Before (1st) vs. after control period (6th wk)

  9. Baseline characteristics

    * functional and exercise parameters * cardiovascular parameters * metabolic parameters * sleep and quality of life parameters (Short Form (36) Health Survey) * physical activity

    Time frame: Before control period (1st week) or after the control period (6th week)

07

Study locations

2 sites
  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
    Quebec, GIV 4G5, Canada
  • Hopital Universitaire de Grenoble
    Grenoble, 38043, France
08

References and documents

Publications

  • Vivodtzev I, Tamisier R, Croteau M, Borel JC, Grangier A, Wuyam B, Levy P, Minville C, Series F, Maltais F, Pepin JL. Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial. Thorax. 2018 Feb 20:thoraxjnl-2017-211152. doi: 10.1136/thoraxjnl-2017-211152. Online ahead of print. PubMed 29463621 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2010, a primary completion of Dec 2014 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2010
First posted
Jul 1, 2010
Start
Jul 2010
Primary completionActual
Dec 2014
CompletionEst.
Dec 2018
Last update
Oct 2, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01155271
Lead sponsor
AGIR à Dom
Responsible party
Sponsor
First posted
Jul 1, 2010
Start date
Jul 2010
Primary completion
Dec 2014
Completion
Dec 2018 (estimated)
Last update
Oct 2, 2018

Study contacts

Jean-Louis Pepin, MD, PhD
principal investigator · Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion